All4NutraNo products in the cart.
All4NutraStartseite » Solubility Enhancement » Page 15
Abstract Background/Objectives: Amorphization of an active pharmaceutical ingredient (API) can improve its dissolution and enhance bioavailability. Avoiding solvents for drug amorphization...
Abstract The increasing popularity of prolonged-release dosage forms, owing to their ability to provide continuous drug release after administration, has...
Developing a formulation for the oral route is a long and complex journey in which the API (Active Pharmaceutical Ingredient)...
Abstract Nanoparticles (NPs) have gained significant attention in recent years due to their potential applications in pharmaceutical formulations, drug delivery...
This study aims to enhance the solubility of Olaparib, classified as biopharmaceutical classification system (BCS) class IV due to its...
Abstract Hepatocellular carcinoma (HCC) is a cancer with high incidence and mortality rates worldwide. In the various treatment methods for...
Diabetes is a long-term metabolic disorder caused by issues with insulin production or response in the body. This leads to...
Emerging and reemerging viruses pose significant public health threats, underscoring the urgent need for new antiviral drugs. Recently, a novel...
The present study aimed to develop and optimize solidified supersaturated self-nanoemulsifying drug delivery systems (SNEDDS) for the combined administration of...
This poster was presented at EuPFI 2024 in Rotterdam. Introduction Loratadine, an antihistamine medication, is widely prescribed for the treatment...
Copyright: PharmaExcipients AG